{
    "2021-12-08": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Eli Lilly's Pipeline Strength Paints a Promising Outlook",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Pipeline",
                        "Strength",
                        "Promising Outlook"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "UPDATE 2-China approves Brii Biosciences antibody COVID treatment",
                "features": {
                    "keywords": [
                        "China",
                        "approves",
                        "Brii Biosciences",
                        "antibody",
                        "COVID treatment"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}